Crossmark Global Holdings Inc. Sells 227 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV)

Crossmark Global Holdings Inc. trimmed its position in Shockwave Medical, Inc. (NASDAQ:SWAVFree Report) by 3.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,180 shares of the company’s stock after selling 227 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Shockwave Medical were worth $1,178,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. Armistice Capital LLC increased its stake in Shockwave Medical by 168.0% during the fourth quarter. Armistice Capital LLC now owns 426,057 shares of the company’s stock worth $81,189,000 after acquiring an additional 267,055 shares during the last quarter. Eisler Capital UK Ltd. bought a new stake in Shockwave Medical during the fourth quarter worth approximately $611,000. Rhenman & Partners Asset Management AB increased its stake in Shockwave Medical by 72.8% during the fourth quarter. Rhenman & Partners Asset Management AB now owns 140,000 shares of the company’s stock worth $26,678,000 after acquiring an additional 59,000 shares during the last quarter. NEOS Investment Management LLC bought a new stake in Shockwave Medical during the fourth quarter worth approximately $302,000. Finally, KBC Group NV bought a new stake in Shockwave Medical during the fourth quarter worth approximately $135,000. 95.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on SWAV shares. Piper Sandler boosted their price objective on Shockwave Medical from $290.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $335.00 target price (up previously from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Leerink Partnrs lowered Shockwave Medical from an “outperform” rating to a “market perform” rating in a research report on Friday, April 5th. CL King restated a “neutral” rating on shares of Shockwave Medical in a research report on Monday, April 8th. Finally, Morgan Stanley restated an “equal weight” rating and set a $335.00 target price (up previously from $285.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Ten investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $309.11.

Read Our Latest Stock Analysis on Shockwave Medical

Shockwave Medical Stock Down 0.0 %

Shockwave Medical stock opened at $334.75 on Monday. The business has a fifty day moving average of $329.87 and a two-hundred day moving average of $263.22. The company has a quick ratio of 12.61, a current ratio of 13.81 and a debt-to-equity ratio of 0.97. The firm has a market cap of $12.57 billion, a P/E ratio of 78.21, a P/E/G ratio of 2.43 and a beta of 0.88. Shockwave Medical, Inc. has a twelve month low of $157.00 and a twelve month high of $334.90.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last posted its earnings results on Monday, May 6th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. The company had revenue of $218.80 million during the quarter, compared to analyst estimates of $207.69 million. Shockwave Medical had a return on equity of 24.79% and a net margin of 20.75%. Shockwave Medical’s revenue was up 35.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.03 earnings per share. On average, analysts forecast that Shockwave Medical, Inc. will post 5.05 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the sale, the insider now owns 56,818 shares in the company, valued at $16,344,834.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the transaction, the insider now directly owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Laura Francis sold 1,500 shares of the company’s stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now directly owns 3,551 shares in the company, valued at $1,065,300. The disclosure for this sale can be found here. 3.40% of the stock is owned by company insiders.

Shockwave Medical Profile

(Free Report)

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Featured Articles

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.